NONINVASIVE AND CURATIVE RADIATION THERAPY FOR SEBACEOUS CARCINOMA OF THE EYELID

被引:34
作者
Hata, Masaharu [1 ]
Koike, Izumi
Omura, Motoko
Maegawa, Jiro [2 ]
Ogino, Ichiro [3 ]
Inoue, Tomio
机构
[1] Yokohama City Univ, Grad Sch Med, Dept Radiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Yokohama, Kanagawa 2360004, Japan
[3] Yokohama City Univ, Med Ctr, Dept Radiat Oncol, Yokohama, Kanagawa 2360004, Japan
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 82卷 / 02期
关键词
Eyelid; Organ preservation; Radiation therapy; Sebaceous carcinoma; MEIBOMIAN GLAND CARCINOMA; ORBITAL LYMPHOMA; PAGETOID SPREAD; CELL-CARCINOMA; ONCOLOGY-GROUP; OCULAR ADNEXA; MITOMYCIN-C; MANAGEMENT; RADIOTHERAPY; ADENOCARCINOMA;
D O I
10.1016/j.ijrobp.2010.12.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Sebaceous carcinoma of the eyelid is a rare malignancy. Surgical excision remains the standard and most reliable curative treatment. However, surgery is sometimes not possible because many patients are elderly, and it frequently causes functional and cosmetic impairment of the eyelid. We therefore carried out a study to determine: the role of radiation therapy in relation to sebaceous carcinoma of the eyelid. Methods and Materials: Thirteen patients with sebaceous carcinoma of the eyelid underwent radiation therapy with curative intent. There were 6 men and 7 women, and their ages at irradiation ranged from 60 to 85 years (me.. dian, 78 years). Only 1 patient had cervical lymph node metastasis, and none of the patients had distant metastasis. A total dose of 50 to 66.6 Gy (median, 60 Gy) was delivered to tumor sites in 22 to 37 fractions. Results: All irradiated tumors were controlled at a median follow-up period of 55 months. Only 1 patient had re.. currence of cervical lymph node metastasis outside the radiation field, at 22 months after irradiation. The 5-year local progression free and disease-free rates were 100% and 89%, respectively. The overall and disease-free sur. vival rates at 5 years were 100% and 89%, respectively. Although acute and transient therapy-related reactions of Grade 2 or less were observed, there were no severe toxicities of Grade 3 or greater. Conclusions: Radiation therapy is a safe and effective treatment for patients with sebaceous carcinoma of the eye.. lid. It appears to contribute to prolonged survival as a result of good tumor control, and it also facilitates functional and cosmetic preservation of the eyelid. (C) 2012 Elsevier Inc.
引用
收藏
页码:605 / 611
页数:7
相关论文
共 50 条
  • [41] Sebaceous carcinoma of the eyelid: demographical analysis and role of surgery in the management
    Abdul Qahar Khan Yasinzai
    Mya Goodbee
    Jennifer Ahweyevu
    Abdul Samad Khan Tareen
    Hafeez Ullah
    Muhammad Ayub Tareen
    Abdul Waheed
    Adil Karim
    Dauod Arif
    Marjan Khan
    Luis Brandi
    Asad Ullah
    European Journal of Plastic Surgery, 2023, 46 : 1011 - 1018
  • [42] Expression of alpha-crystallins in human sebaceous carcinoma of the eyelid
    Rigas, Panayota K.
    Kase, Satoru
    Rao, Narsing A.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2009, 19 (05) : 702 - 707
  • [43] Recurrence in Eyelid Sebaceous Carcinoma: A Multicentric Study of 418 Patients
    Xu, Mingpeng
    Chen, Qian
    Luo, Yingxiu
    Chai, Peiwei
    He, Xiaoyu
    Huang, Hengye
    Tan, Jia
    Ye, Juan
    Zhou, Chuandi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (10)
  • [44] Sebaceous Carcinoma of the Eyelid: Proposed Nomenclature for Multifocal and Multicentric Disease
    Magazin, Maja
    Dalvin, Lauren A.
    Salomao, Diva R.
    Castner, Nicholas B.
    Halbach, Caroline
    Tooley, Andrea A.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2023, 39 (02) : 117 - 122
  • [45] Association of AJCC pT category with outcome in sebaceous carcinoma of the eyelid
    White, Valerie
    Mulay, Kaustubh
    Agrawal, Sneha
    Honavar, Santosh
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [46] Sebaceous Carcinoma of the Penis
    Ornellas, Antonio Augusto
    Frota, Rodrigo
    Lopes da Silva, Luis Felipe
    Dauster, Breno
    Quirino, Raul
    de Santos Schwindt, Aline Barros
    Pereira, Maria Rita
    UROLOGIA INTERNATIONALIS, 2009, 82 (04) : 477 - 480
  • [47] Collision tumor of sebaceous carcinoma and squamous cell carcinoma of the eyelid: Case report
    Wang, Jin-Jhe
    Lee, Kam-Fai
    Chen, Chau-Yin
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (05) : NP55 - NP59
  • [48] S1-Guideline Sebaceous Carcinoma
    Utikal, Jochen
    Nagel, Pia
    Mueller, Verena
    Becker, Juergen C.
    Dippel, Edgar
    Frisman, Alexander
    Gschnell, Martin
    Griewank, Klaus
    Hadaschik, Eva
    Helbig, Doris
    Hillen, Uwe
    Leiter, Ulrike
    Pfoehler, Claudia
    Kroenig, Lisa
    Ziemer, Mirjana
    Ugurel, Selma
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024, : 730 - 747
  • [49] Regression of Sebaceous Carcinoma of the Eyelid after a Small Incisional Biopsy: Report of Two Cases
    Brownstein, Seymour
    Mehta, Sonul
    Nijhawan, Navdeep
    Allaire, Guy
    Tuan Quynh Tram Nguyen
    Tang, Tina
    Jiang, Kailun
    Saleh, Solin
    Kalin-Hajdu, Evan
    Bruen, Robbin
    Oestrelcher, James
    OCULAR ONCOLOGY AND PATHOLOGY, 2018, 5 (04) : 252 - 257
  • [50] A Retrospective Review of 1349 Cases of Sebaceous Carcinoma
    Dasgupta, Tina
    Wilson, Lynn D.
    Yu, James B.
    CANCER, 2009, 115 (01) : 158 - 165